FAM122C activators encompass a spectrum of compounds that influence various intracellular signaling cascades resulting in the activation of this protein. Compounds that elevate intracellular cAMP levels, such as those that directly stimulate adenylyl cyclase or inhibit phosphodiesterases, lead to an increase in protein kinase A activity. This kinase, being cAMP-dependent, phosphorylates target proteins and could thereby augment the activity of FAM122C. Similarly, analogs of cAMP that permeate the cell membrane also activate these pathways, resulting in a potential increase in FAM122C activity through the same kinase-mediated mechanism. Additionally, alterations in intracellular calcium levels, either through the use of ionophores or calcium channel activators, may activate calcium-dependent protein kinases, which in turn could enhance the functional activity of FAM122C. The modulation of cellular ion balances through the inhibition of ion pumps is another route through which FAM122C activity may be influenced, as these changes can affect various signaling molecules and pathways that indirectly lead to the activation of FAM122C.
Further intricacies of FAM122C activation involve compounds that target protein kinase C, a kinase that is activated by certain phorbol esters, and in turn, can modulate numerous downstream proteins and pathways potentially leading to the activation of FAM122C. Beta-adrenergic receptor agonists also contribute to the elevation of cAMP and subsequent PKA activation, serving as yet another indirect route to enhance FAM122C activity. Additionally, the broad inhibition of tyrosine kinases may result in the alteration of multiple signaling pathways, which could culminate in the increased activity of FAM122C. The intricate network of signaling pathways that these activators engage with ultimately converge on the modulation of FAM122C, thereby increasing its functional role in the cell.
SEE ALSO...
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $159.00 $315.00 $598.00 | 34 | |
Non-specific inhibitor of phosphodiesterases, leading to increased cAMP and cGMP levels, potentially enhancing FAM122C activity via protein kinase A. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $45.00 $130.00 $480.00 $4450.00 | 74 | |
Cell-permeable cAMP analog that activates cAMP-dependent pathways, potentially increasing FAM122C activity through activation of protein kinase A. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $54.00 $128.00 $199.00 $311.00 | 23 | |
Increases intracellular calcium, possibly activating calcium-dependent protein kinases, which could lead to activation of FAM122C. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
Activates protein kinase C, which could enhance the activity of FAM122C through downstream signaling pathways. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
A calcium ionophore that raises intracellular calcium levels, potentially activating calcium-dependent pathways that could activate FAM122C. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $27.00 $37.00 | 5 | |
Agonist of beta-adrenergic receptors, leading to increased cAMP and activation of protein kinase A, which may indirectly activate FAM122C. | ||||||
Ouabain-d3 (Major) | sc-478417 | 1 mg | $506.00 | |||
Inhibits the Na+/K+ ATPase, leading to alterations in cellular ion balances and signaling that could indirectly activate FAM122C. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $75.00 $212.00 | 18 | |
PDE4 inhibitor that increases cAMP levels, potentially leading to the activation of FAM122C through cAMP-dependent protein kinase A. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $26.00 $92.00 $120.00 $310.00 $500.00 $908.00 $1821.00 | 46 | |
Tyrosine kinase inhibitor that could indirectly enhance FAM122C activity through modulation of downstream signaling pathways. |